StockWatch
·
Pharmaceuticals
Quarterly Result20 May 2026, 07:01 pm

Gujarat Inject Kerala: Audited Standalone Results for FY26

AI Summary

Gujarat Inject Kerala Ltd approved audited standalone financial results for the fourth quarter and year ended March 31, 2026, in a board meeting held on May 20, 2026. The board also took on record the audit report issued by M/s. S. Mandawat & Co., Statutory Auditors, with an unmodified opinion on the statement. The audit firm, S. MANDAWAT & CO., conducted the audit in accordance with the Standards on Auditing and issued an independent Auditor's Report with an unmodified opinion.

Key Highlights

  • Gujarat Inject Kerala approved audited standalone financial results for FY26.
  • M/s. S. Mandawat & Co. issued an audit report with an unmodified opinion.
  • The Board meeting commenced at 5:10 P.M and concluded at 5:55 P.M on May 20, 2026.
  • The financial results are compliant with Regulation 33 of SEBI Listing Regulations.